EUVIMEDEUVIMED entdecken
Open Access

AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model

Hui-Ying Ko, Ya-Yuan Li, Yogy Simanjuntak, Han-Peng Yu, Ming-Tsai Chiang, Che-Yu Lee, Jian-Jong Liang, Yi-Ling Lee, Cheng-Pu Sun, Po-Sheng Wang, Pei-Yun Shu, Tsai-Ying Yen und 2 weitere

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.09.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Hui-Ying Ko und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan. Electronic address: ribsome@ibms.sinica.edu.tw. Hauptthemen laut MEDLINE: Dependovirus, Zika Virus, Dengue Virus, Genetic Vectors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and Technology, Taiwan, Academia Sinica, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses contain many important human pathogens such as dengue virus (DENV) and Zika virus (ZIKV), for which effective and safe vaccines are still lacking, mainly because preexisting cross-reactive non-neutralizing antibodies may exacerbate subsequent infections with related flaviviruses. To overcome this challenge, we explore vectored immunoprophylaxis (VIP), which involves the passive transfer of protective antibody genes via viral vectors for in vivo expression. We utilized a recombinant adeno-associated virus (rAAV) to express a broad anti-flavivirus neutralizing human monoclonal antibody, bnAb 752-2C8, and tested its protection against four serotypes of DENV and ZIKV. The bnAb 752-2C8 antibody gene was cloned into an AAV plasmid and the rAAV was successfully generated to express bnAb 752-2C8. After a single dose of rAAV administration into AGB6 mice, the human antibody concentrations increased to ∼1,000 μg/mL and remained elevated for at least 48 weeks. VIP-treated mice were completely protected from a lethal challenge of DENVs and ZIKV, while control mice without bnAb 752-2C8 succumbed to infection. Our results demonstrate the effectiveness of rAAV in delivering bnAb 752-2C8 for long-term protection against multiple flaviviruses, providing a potential strategy to control flavivirus infections and possibly other viral diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusZika VirusDengue VirusGenetic VectorsZika Virus InfectionAntibodies, NeutralizingAntibodies, ViralDengueAntibodies, MonoclonalAnimalsMiceHumansDisease Models, AnimalFemale

Stichwörter der Autor:innen

ADEVIPZika virusantibody-dependent enhancementbroadly neutralizing antibodydengue virusflaviviruslong-term immunityrAAVrecombinant adeno-associated virusvectored immunoprophylaxis

Substanzen

Antibodies, NeutralizingAntibodies, ViralAntibodies, Monoclonal

Autor:innen und Institutionen

  • Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan. Electronic address: ribsome@ibms.sinica.edu.tw.
  • Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan; Institute of Microbiology and Immunology, National Defense Medical Center, Taipei 114201, Taiwan.
  • Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan.
  • Biomedical Translation Research Center, Academia Sinica, Taipei 115201, Taiwan.
  • Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei 115201, Taiwan.
  • Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan; Biomedical Translation Research Center, Academia Sinica, Taipei 115201, Taiwan.

Förderung

  • Ministry of Science and Technology, Taiwan
  • Academia Sinica
  • National Science and Technology Council

Zitieren

APA

Ko, H. Y., Li, Y. Y., Simanjuntak, Y., Yu, H. P., Chiang, M. T., Lee, C. Y., Liang, J. J., Lee, Y. L., Sun, C. P., Wang, P. S., Shu, P. Y., Yen, T. Y., Tao, M. H., & Lin, Y. L. (2025). AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.09.007

Vancouver

Ko HY, Li YY, Simanjuntak Y, Yu HP, Chiang MT, Lee CY, et al. AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.09.007

BibTeX
@article{Ko2025,
  author = {Ko, Hui-Ying and Li, Ya-Yuan and Simanjuntak, Yogy and Yu, Han-Peng and Chiang, Ming-Tsai and Lee, Che-Yu and Liang, Jian-Jong and Lee, Yi-Ling and Sun, Cheng-Pu and Wang, Po-Sheng and Shu, Pei-Yun and Yen, Tsai-Ying and Tao, Mi-Hua and Lin, Yi-Ling},
  title = {AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.09.007}
}
Kostenlos starten →